About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:7493591
Allelic
Composition
Chd7Gt(S20-7E1)Sor/Chd7+
Genetic
Background
129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chd7Gt(S20-7E1)Sor mutation (1 available); any Chd7 mutation (138 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• female mice exhibit delayed puberty
• vaginal opening is significantly delayed and occurs an average of 5 days later than in wild-type females (P32 versus P27)
• however, vaginal opening occurs at a body size of ~15 gm, similar to wild-type females
• female mice never achieve cyclicity and exhibit highly erratic estrus cycles, with no apparent pattern of timing or duration of cycle stages
• female mice achieve first estrus on P43, that is, 10 days later than wild-type females (P33)
• females have first estrus at a body size of ~15 gm, whereas wild-type females have first estrus at ~18 gm

taste/olfaction
• 10% decrease in the number of basal cells
• cilia markers are consistently patchy indicating regional decreases in cilia components
• patchy distribution is confirmed by SEM
• the normal arrangement in parallel stacked columns in the epithelium is lost
• 30% reduction in number
• E10.5 embryos show a 49% reduction in phospho-histone H3-positive proliferating cells in the olfactory placode relative to wild-type controls
• embryos exhibit a significant reduction in TUNEL-positive cells in the nasal region relative to wild-type embryos at E10.5 (-21%), E11.5 (-11%) and E12.5 (-13%]
• expression levels of Otx2, Bmp4 and Fgfr1 (involved in proliferation and/or neurogenesis) are significantly decreased in the olfactory placode at E10.5
• however, the size of the E10.5 olfactory placode is normal and invagination of the olfactory placode to form the olfactory pit appears unaffected
• 50% reduction in proliferating basal cells in adults
• 4 and 8 weeks after chemical ablation neuronal regeneration is impaired or delayed
• little to no response to 6 different odorants (amyl acetate, octanal, haptaldehyde, hexanal, eugenol, and carvone) tested by electro-olfactogram

nervous system
• GnRH neurogenesis is impaired resulting in reduced GnRH neurons in embryos and adult mice
• the normal arrangement in parallel stacked columns in the epithelium is lost
• 30% reduction in number
• adult male and female mice show, respectively, a 51% and 54% reduction in anti-GnRH immunofluorescence in the median eminence
• however, immunofluorescence of arginine vasopressin (AVP)-positive fibers in the median eminence is normal
• expression levels of Gnrhr (gonadotropin releasing hormone receptor) are significantly reduced in the adult pituitary gland
• decreased length
• decreased length but not width
• however, intact OMP-positive olfactory bulb glomeruli are present
• both adult male and female mice show a 35% reduction in the total number of GnRH-positive neuron cell bodies in the hypothalamus relative to wild-type controls
• embryos show a 30% reduction in the total number of GnRH-positive neurons in the nasal region at E11.5 and E12.5, consistent with fewer GnRH neurons in the adult hypothalamus
• however, GnRH neurons show normal distribution throughout the rostral-caudal axis from the nasal region to the cerebellum, suggesting normal GnRH neuronal migration
• expression levels of Gnrh1 (gonadotropin releasing hormone 1) and Otx2 (orthodenticle homeobox 2) are significantly reduced in the adult hypothalamus
• reduced olfactory interneuron activity
• 4 and 8 weeks after chemical ablation neuronal regeneration is impaired or delayed

homeostasis/metabolism
N
• both male and female mice show normal serum levels of growth hormone (GH) and insulin-like growth factor I (IGF1) relative to wild-type controls
• 2 h after administration of leuprolide, a GnRH agonist, both male and female mice show a normal increase in serum levels of LH and FSH relative to similarly treated wild-type controls
• female mice show normal serum levels of insulin and leptin relative to wild-type females
• 2 h after administration of antide, a gonadotropin-releasing hormone (GnRH) antagonist, male mice show a normal decrease in serum levels of LH and FSH relative to similarly treated wild-type controls
• at late estrus, 3-4-month-old female mice show an 83% reduction in serum FSH levels relative to wild-type controls
• in contrast, male mice show normal serum FSH levels
• at late estrus, 3-4-month-old female mice show a 74% reduction in serum LH levels relative to wild-type controls
• male mice show an 86% reduction in serum LH levels relative to wild-type controls

cellular
• cilia markers are consistently patchy indicating regional decreases in cilia components
• patchy distribution is confirmed by SEM
• embryos exhibit a significant reduction in TUNEL-positive cells in the nasal region relative to wild-type embryos at E10.5 (-21%), E11.5 (-11%) and E12.5 (-13%]
• GnRH neurogenesis is impaired resulting in reduced GnRH neurons in embryos and adult mice
• E10.5 embryos show a 49% reduction in phospho-histone H3-positive proliferating cells in the olfactory placode relative to wild-type controls

endocrine/exocrine glands
N
• mice show normal pituitary gland histology at E10.5, E14.5, E18.5 and in adulthood
• adult male and female mice show, respectively, a 51% and 54% reduction in anti-GnRH immunofluorescence in the median eminence
• however, immunofluorescence of arginine vasopressin (AVP)-positive fibers in the median eminence is normal
• expression levels of Gnrhr (gonadotropin releasing hormone receptor) are significantly reduced in the adult pituitary gland

growth/size/body
• 10% decrease in the number of basal cells
• cilia markers are consistently patchy indicating regional decreases in cilia components
• patchy distribution is confirmed by SEM
• the normal arrangement in parallel stacked columns in the epithelium is lost
• 30% reduction in number
• both male and female mice are significantly smaller than wild-type controls

respiratory system
• 10% decrease in the number of basal cells
• cilia markers are consistently patchy indicating regional decreases in cilia components
• patchy distribution is confirmed by SEM
• the normal arrangement in parallel stacked columns in the epithelium is lost
• 30% reduction in number
• 50% reduction in proliferating basal cells in adults
• 4 and 8 weeks after chemical ablation neuronal regeneration is impaired or delayed

craniofacial
• 10% decrease in the number of basal cells
• cilia markers are consistently patchy indicating regional decreases in cilia components
• patchy distribution is confirmed by SEM
• the normal arrangement in parallel stacked columns in the epithelium is lost
• 30% reduction in number

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
CHARGE syndrome DOID:0050834 OMIM:214800
J:148116 , J:174086


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory